[특허]Compositions and methods for delivery of frozen particle adhesives

The Invention Science Fund I, LLC

검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
검색연산자

검색도움말
검색연산자	기능	검색시 예
()	우선순위가 가장 높은 연산자	예1) (나노 (기계 \| machine))
공백	두 개의 검색어(식)을 모두 포함하고 있는 문서 검색	예1) (나노 기계) 예2) 나노 장영실
\|	두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색	예1) (줄기세포 \| 면역) 예2) 줄기세포 \| 장영실
!	NOT 이후에 있는 검색어가 포함된 문서는 제외	예1) (황금 !백금) 예2) !image
*	검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색	예) semi*
""	따옴표 내의 구문과 완전히 일치하는 문서만 검색	예) "Transform and Quantization"

과학기술 지식인프라 ScienceON

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기

내보내기 페이스북 공유 트위터 공유 카카오톡 공유

Compositions and methods for delivery of frozen particle adhesives

특허상세정보
국가/구분	United States(US) Patent 등록
국제특허분류(IPC7판)	A61K-009/00 A61K-009/16 A61K-009/08 A61K-031/00 A61K-051/12 A61K-009/19 A61K-031/10 A61K-031/337 A61K-031/70 A61K-031/7088 A61K-033/00 A61K-041/00 A61K-045/06 A61K-049/18 A61K-039/00
출원번호	US-0383263 (2009-03-20)
등록번호	US-9050251 (2015-06-09)
발명자 / 주소	Boyden, Edward S. Cook, Daniel B. Hyde, Roderick A. Leuthardt, Eric C. Myhrvold, Nathan P. Sweeney, Elizabeth A. Wood, Jr., Lowell L.
출원인 / 주소	The Invention Science Fund I, LLC
인용정보	피인용 횟수 : 3 인용 특허 : 144

초록

Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

대표
청구항
▼

1. A frozen particle composition, comprising: one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 2. The frozen particle composition of claim 1, wherein the at least one major dimension includes at least one of the radius, diameter, length, width, height, or perimeter. 3. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one of a monomer, prepolymer, polymer, or copolymer. 4. The frozen particle composition of claim 1, further including at least one material that solidifies in situ at physiological temperature and pH. 5. The frozen particle composition of claim 1, wherein one or more bone morphogenic proteins are encapsulated by the vesicle. 6. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one crosslinking or derivatized agent. 7. The frozen particle composition of claim 1, wherein one or more integrin peptides are encapsulated by the vesicle. 8. The frozen particle composition of claim 7, wherein one or more silica beads are encapsulated by the vesicle. 9. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes a methacrylate. 10. The frozen particle composition of claim 8, wherein the at least one adhesive agent includes at least one of poly(N,N-dimethyl-N-(ethoxycarbonylmethyl)-N-[2′-(methacryloyloxy)ethyl]-ammonium bromide) or poly(sulfobetaine methacrylate). 11. The frozen particle composition of claim 1, further including at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit. 12. The frozen particle composition of claim 11, wherein the detection material includes at least one electronic identification device. 13. The frozen particle composition of claim 12, wherein the at least one electronic identification device includes at least one radio frequency identification device. 14. The frozen particle composition of claim 11, wherein the detection material includes at least one radioactive element. 15. The frozen particle composition of claim 14, wherein the at least one radioactive element includes one or more of 32P, 35S, 13C, 131I, 191Ir, 192Ir, 193Ir, 201Tl, or 3H. 16. The frozen particle composition of claim 11, wherein the detection material includes at least one luminescent, colorimetric, or odorous substance. 17. The frozen particle composition of claim 11, wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle. 18. The frozen particle composition of claim 1, further including one or more explosive materials. 19. The frozen particle composition of claim 18, wherein the one or more explosive materials include at least one of a carbonate, carbon dioxide, nitroglycerine, acid, base, epoxy, acrylic polymer or copolymer, acrylamide polymer or copolymer, urethane, hypoxyapatite, or a reactive metal. 20. The frozen particle composition of claim 1, wherein the at least one adhesive agent is frozen. 21. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes at least one a-cyanoacrylate and a fluorescent compound including at least one of a bis-benzoxazolyl compound, pyrylium salt, quantum dot, or coumarin compound. 22. The frozen particle composition of claim 1, wherein the at least one adhesive agent includes an α-cyanoacrylate and 2,5-bis-(5-tert-butyl-2-benzoxasolyl)-thiophene. 23. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 24. The frozen particle composition of claim 1, wherein the at least one adhesive agent further includes at least one curing component. 25. The frozen particle composition of claim 1, wherein the adhesive agent includes at least one dye coinitiator. 26. A method for providing at least one adhesive agent to at least one substrate, comprising: administering at least one frozen particle composition to at least one substrate,wherein the at least one frozen particle composition includes one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 27. The method of claim 26, wherein the at least one frozen particle composition is in at least one crystalline or amorphous phase. 28. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of the at least one substrate. 29. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one biological tissue. 30. The method of claim 26, wherein the at least one adhesive agent is configured to polymerize at or above the temperature of at least one subject. 31. The method of claim 26, wherein the at least one substrate includes one or more of a cell, tissue, organ, structure, or device. 32. The method of claim 31, wherein the structure includes one or more of a prosthesis, cell matrix, or tissue matrix. 33. The method of claim 31, wherein the device includes at least one mechanical or electrical device. 34. The method of claim 26, wherein the at least one substrate includes at least one implantable substrate. 35. The method of claim 26, wherein the at least substrate includes at least one cell mass. 36. The method of claim 26, wherein the at least one substrate includes one or more wounds. 37. The method of claim 36, wherein the one or more wounds are located in at least one biological tissue including at least one of skin tissue, muscle tissue, eye tissue, an organ, connective tissue, fetal tissue, nervous tissue, peritoneal tissue, neoplastic tissue, or bone tissue. 38. The method of claim 26, wherein administering at least one frozen particle composition to at least one substrate includes accelerating, propelling, or ejecting the frozen particle composition toward the at least one substrate. 39. The method of claim 26, further including varying the rate, velocity, or angle at which the at least one frozen particle composition is administered to at least one substrate. 40. The method of claim 26, further including a plurality of frozen particle compositions, wherein two or more of the plurality of frozen particle compositions include two or more adhesive agents are configured to physically or chemically bind upon administration. 41. The method of claim 26, further including administering to the at least one substrate at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit. 42. The method of claim 26, wherein the at least one adhesive agent includes a detectable state that varies with its adhesive state. 43. The method of claim 26, wherein the at least one adhesive agent further includes one or more of a base component, initiator component, or activator component. 44. The method of claim 26, wherein the at least one adhesive agent further includes at least one curing component. 45. The method of claim 26, wherein the adhesive agent includes at least one dye coinitiator. 46. A method of maintaining the approximation of tissue of the at least one wound of a subject, comprising: administering at least one frozen particle composition to at least one wound of a subject for a time sufficient to maintain the approximation of tissue of the at least one wound;wherein the at least one frozen particle composition includes one or more frozen saline solution particles including at least one adhesive agent substantially in the form of a vesicle and including an acrylic polymer;and wherein the frozen particle composition is externally coated with at least one anesthetic, analgesic, or antimicrobial agent, wherein the analgesic or anesthetic includes at least one of an aminoamid or aminoester local anesthetic, ibuprofen, morphine, codeine, lidocaine/lignocaine, ropivacaine, mepivacaine, benzocaine, chloroprocaine, cyclomethycaine, dimethocaine/larocaine, propoxycaine, procaine/novocaine, proparacaine, tetracaine/amethocaine, articaine, bupivacaine, carticaine, cinchocaine/dibucaine, etidocaine, levobupivacaine, piperocaine, prilocaine, trimecaine, saxitoxin, tetrodotoxin, acetaminophen, a non-steroidal anti-inflammatory drug, salicylate, narcotic, or tramadol; and wherein the antimicrobial agent includes at least one of an anti-fungal agent, antibiotic agent, anti-bacterial agent, anti-parasitic agent, or anti-worm agent. 47. The method of claim 46, wherein administering at least one frozen particle composition to at least one substrate includes accelerating, propelling, or ejecting the frozen particle composition toward the at least one substrate. 48. The method of claim 46, further including varying the rate, velocity, or angle at which the at least one frozen particle composition is administered to at least one wound. 49. The frozen particle composition of claim 1, wherein the adhesive agent further includes at least one of urethane, gum Arabic, polyester, polyhydroxyalkanoate, poly(L-lactic acid), polyglycolide, polylactic acid, polyether, polyol, polyvinylpyrrolidone, pyroxylin, polymethylacrylate-isobutene-monoisopropylmaleate, siloxane polymer, polylactic-co-glycolic-acid, poly-3-hydroxybutyrate, poly-4-hydroxybutyrate, polyhydroxyvalerate, polydydroxyhexanoate, polydyroxyoctanoate, polycaprolactone, poly (e-caprolactone), sialyl Lewisx, heme group, hemoglobin, healon, carboxymethylcellulose, silicone, cadherin, integrin, hydroxyapatite, polyelectrolyte, maleic polyelectrolyte, cellulose, resilin, cyanoacrylate, isocyanate, 2-octyl cyanoacrylate, 2-butyl-n-cyanoacrylate, n-butyl-2-cyanoacrylate, butyl-2-cyanoacrylate, methyl 2-cyanoacrylate, polyisohexylcyanoacrylate, fibrin, thrombin, fibrinogen, hyaluronate, chitin, Factor XIII, Factor XII, silk, nylon, collagen, glycosaminoglycan, selectin, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, albumin, glutaraldehyde, or polyethylene glycol. 50. The frozen particle composition of claim 1, wherein the frozen solution of saline in water further includes a surfactant in the frozen solution. 51. The frozen particle composition of claim 1, further including at least one anti-inflammatory agent. 52. The frozen particle composition of claim 1, further including at least one angiogenic factor. 53. The frozen particle composition of claim 1, further including at least one cytokine. 54. The frozen particle composition of claim 1, further including at least one coagulant. 55. The frozen particle composition of claim 1, further including at least one cytotoxic agent. 56. A frozen particle composition, comprising: one or more frozen salt buffer solution particles containing at least one acrylic polymer substantially in the form of a vesicle and encapsulating at least one antibody;wherein the one or more frozen salt buffer solution particles are a frozen solution in particle form of at least one salt buffer including TRIS-buffered saline, standard saline citrate, HEPES-buffered saline, Ringer's solution, lactated Ringer's solution, Hank's balanced salt solution, Earle's balanced salt solution, Hartmann's solution, HEPES buffer, or phosphate buffered solution, and further include zinc oxide powder and phosphoric acid; andwherein the frozen salt buffer solution particles have at least one major dimension of approximately one micrometer or less, approximately one nanometer or less, or any value therebetween. 57. The frozen particle composition of claim 56, further including methyl methacrylate and polymethyl methacrylate. 58. The frozen particle composition of claim 56, further including at least one cytotoxic agent. 59. A frozen particle composition, comprising: one or more frozen dimethyl sulfoxide solution particles containing at least one adhesive agent of acrylic polymer, polylactic acid, poly (L-lactic acid), polyethylene glycol, polyol, polyether, polyol, polyvinylpyrrolidone, pyroxylin, polymethylacrylate-isobutene-monoisopropylmaleate, siloxane polymer, polylactic-co-glycolic-acid, poly-3-hydroxybutyrate, poly-4-hydroxybutyrate, polyhydroxyvalerate, polydydroxyhexanoate, polydyroxyoctanoate, polycaprolactone, poly (e-caprolactone), sialyl Lewisx, heme group, hemoglobin, healon, carboxymethylcellulose, hydroxyapatite, silicone, cadherin, integrin, polyelectrolyte, maleic polyelectrolyte, cellulose, resilin, cyanoacrylate, isocyanate, 2-octyl cyanoacrylate, 2-butyl-n-cyanoacrylate, n-butyl-2-cyanoacrylate, butyl-2-cyanoacrylate, methyl 2-cyanoacrylate, polyisohexylcyanoacrylate, fibrin, thrombin, fibrinogen, hyaluronate, chitin, Factor XIII, Factor XII, silk, nylon, collagen, glycosaminoglycan, selectin, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, albumin, glutaraldehyde or gelatin substantially in the form of a vesicle and encapsulating at least one stem cell;one or more reinforcement agents of kaolin, or cellulose;wherein the one or more frozen dimethyl sulfoxide solution particles are a frozen solution of dimethyl sulfoxide, and wherein the frozen dimethyl sulfoxide solution particles have at least one major dimension of approximately one micrometer or less, approximately one nanometer or less, or any value therebetween. 60. The frozen composition of claim 59, wherein the frozen dimethyl sulfoxide solution particles further include at least one coagulant, anti-coagulant, anesthetic, antimicrobial agent, anti-inflammatory, or analgesic.

이 특허에 인용된 특허 (144)

Dennis Edward A. (1921 Hypatia Way La Jolla CA 92037-3322). Prodrugs. USP1994105352673.

Meyer Bernard H. (Newtown Square PA) Kinslow Joseph C. (Media PA). Purification, impregnation and foaming of polymer particles with carbon dioxide. USP1991095049328.

St. Clair David J. (Houston TX) Hansen David R. (Houston TX). Radiation cured polydiene based polymer composition. USP1979054152231.

Laugharn ; Jr. James A. ; Bradley David W. ; Hess Robert A.. Rapid cryobaric sterilization and vaccine preparation. USP2001086270723.

Aono Masao (Mishima JPX) Kanaoka Hiroshi (Suita JPX). Refrigerator with an automatic ice maker. USP1992025090208.

Van Meter,Kyle B.; Martin,Dean A.; Fu,Xiaoyong. Refrigerator with intermediate temperature icemaking compartment. USP2007107284390.

An Yuehuei H. ; Mironov Vladimir A. ; Gutowska Anna. Reversible gelling culture media for in-vitro cell culture in three-dimensional matrices. USP2000086103528.

Thomas D. Petersen. Scalpel with a double grind blade edge and detachable handle. USP2002126500187.

Ellinwood ; Jr. Everett H. (3519 Tonbridge Way Durham NC 27707). Self-powered implanted programmable medication system and method. USP1979034146029.

Geskin, Ernest S.; Goldenberg, Boris. Selfrechargeable gun and firing procedure. USP2004036705194.

Dietl Josef (Neutting DEX) Holm Claus (Baldham DEX) Sirtl Erhard (Marktl DEX). Semicontinuous process for the manufacture of pure silicon. USP1982014312850.

Indlekofer,Markus. Shot-blasting installation for blasting work pieces made from light metal alloys. USP2008097421872.

Padovani Francois A. (Dallas TX). Silicon seed production process. USP1980064207360.

Medina, Augusto S.; Whigham, Roger; Fisher, John J.; Gann, Barbara; Weinaug, Kenneth S.; Staten, Richard. Simulated frozen beverage composition and method of manufacture thereof. USP2004036712237.

Lee Hyeon-Kook,KRX ; Park Jung-Hwan,KRX ; Choi Nam-Sok,KRX ; Kim Myung-Jin,KRX ; Kim Soo-Hyeon,KRX. Single-shot vaccine formulation. USP1998055753234.

Paul J. Weber ; Luiz B. Da Silva ; Michael R. Weber. Skin decoration apparatus and method. USP2002016341831.

Weber Paul J. ; Weber Michael R. ; Da Silva Luiz B.. Skin resurfacing and treatment using biocompatible materials. USP2001106306119.

Stewart ; Jr. William E. (Olathe KS) Greer Michael E. (Gladstone MO) Dona Carol L. G. (Overland Park KS). Slush ice making system and methods. USP1990034907415.

Nikkanen John P.. Snow maker. USP2000106129290.

Galt John,CAX ; Kestle Martin,CAX ; Yetter James,CAX. Sound insulated injection molding machine. USP1998015707667.

Clauss Steven L. (Manville NJ) Pastel Michael J. (Highland Mills NY) Zawadzki Rainer K. (Wuhan CNX). Stable porfimer sodium compositions and methods for their manufacture. USP1995085438071.

Settles Gary S.. Supersonic abrasive iceblasting apparatus. USP1998075785581.

Goenka Lakhi N. (Ann Arbor MI). Supersonic exhaust nozzle having reduced noise levels for CO₂ cleaning system. USP1995025390450.

Peterson Ronald V. (Thousand Oaks CA) Krone-Schmidt Wilfried (Fullerton CA). System for precision cleaning by jet spray. USP1994055315793.

Boyden, Edward S.; Cook, Daniel B.; Hyde, Roderick A.; Leuthardt, Eric C.; Myhrvold, Nathan P.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.. Systems, devices, and methods for making or administering frozen particles. USP2012098256233.

Weber, Paul J.; Da Silva, Luiz B.; Rubenchik, Alexander M.. Tissue removal using biocompatible materials. USP2004076764493.

Weber, Paul J.; Da Silva, Luiz B.; Rubenchik, Alexander M.. Tissue resurfacing using biocompatible materials. USP2004046726693.

Hendler Sheldon S. (La Jolla CA) Sanchez Robert (Carlsbad CA). Tocopherol-based antiviral agents and method of using same. USP1992055114957.

Carter William A.. Treating viral infections associated with chronic fatigue with dsRNA. USP2000106130206.

Marten Klaus (Hilden DEX) Nicolaisen Heinz-Christian (Hanover DEX). UV-fluorescent cyanoacrylate adhesive. USP1988064751020.

Akedo,Jun. Ultra fine particle film forming method and apparatus. USP2006016991515.

Luenemann Brigitte (Alter Fischmarkt 1 D-4400 Munster DEX). Wart treatment. USP1991045006338.

Clark Leland L. (Salt Lake City UT). Wart treatment with phosphonoacetic acid or derivatives thereof. USP1977044016264.

Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J.. Water soluble paclitaxel prodrugs. USP1999115977163.

Santa Cruz Cathy D. ; Deniston-Korgol Christine L. ; Baugh Barbara I. ; Baugh Alexandria D. ; Baugh Roger D.. Weather-proof wrist, forearm, and elbow protectors. USP2000076092235.

Mellinger Gilbert (Jacksonville FL). Weight loss management system. USP1990084951197.

Dean ; Jr. Robert C. (Norwich VT) Silver Frederick H. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Phillips Philip G. (Norwich VT) Runstadler ; Jr. Peter W. (Hanover NH). Weighted collagen microsponge for immobilizing bioactive material. USP1989084861714.

Nadicksbernd, Reinhard. Working chamber system and seal device. USP2004056732424.

이 특허를 인용한 특허 피인용횟수: 3

IPC 상위 출원인

내보내기

상세정보
내보내기 구분	파일저장 인쇄 메일전송
구성항목	관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표IPC 관리번호, 국가코드, 자료구분, 상태, 출원번호, 출원일자, 공개번호, 공개일자, 공고번호, 공고일자, 등록번호, 등록일자, 발명명칭(한글), 발명명칭(영문), 출원인(한글), 출원인(영문), 출원인코드, 대표출원인, 출원인국적, 출원인주소, 발명자, 발명자E, 발명자코드, 발명자주소, 발명자 우편번호, 발명자국적, 대표IPC, IPC코드, 요약, 미국특허분류, 대리인주소, 대리인코드, 대리인(한글), 대리인(영문), 국제공개일자, 국제공개번호, 국제출원일자, 국제출원번호, 우선권, 우선권주장일, 우선권국가, 우선권출원번호, 원출원일자, 원출원번호, 지정국, Citing Patents, Cited Patents
저장형식	Text(ASCII format) Excel format PIAS분석(.xls)
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	> 총 건의 자료가 검색되었습니다. > 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) > 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. > 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) > 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오 > ~ > Text(ASCII format) Excel format

과학기술 지식인프라 ScienceON

ScienceON Chatbot

연합인증

특허 상세정보

Compositions and methods for delivery of frozen particle adhesives

초록

대표
청구항
▼

이 특허에 인용된 특허 (144)

이 특허를 인용한 특허 피인용횟수: 3

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

ScienceON Chatbot

연합인증

특허 상세정보

Compositions and methods for delivery of frozen particle adhesives

초록

대표청구항 ▼

이 특허에 인용된 특허 (144)

이 특허를 인용한 특허 피인용횟수: 3

IPC 상위 출원인

과제정보

상세정보조회

원문조회

IPC 상세정보(version : 201201)

연구과제 성과물(0)

참여연구원의 다른 문헌(0)

처리중입니다.

잠시만 기다려주세요.

대표
청구항
▼